ProQR Therapeutics N.V.
PRQR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,763 | -$27,735 | -$64,204 | -$60,799 |
| Dep. & Amort. | $2,761 | $2,513 | $2,521 | $2,329 |
| Deferred Tax | -$197 | -$78 | $96 | $117 |
| Stock-Based Comp. | $2,544 | $3,106 | $2,869 | $6,216 |
| Change in WC | -$13,264 | $48,956 | -$4,991 | $25,014 |
| Other Non-Cash | -$474 | -$5,214 | -$4,799 | $1,111 |
| Operating Cash Flow | -$36,393 | $21,548 | -$68,508 | -$26,012 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,418 | -$1,371 | -$708 | -$484 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$17,000 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $17,000 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,655 | $5,649 | $6 | $59 |
| Investing Cash Flow | -$4,073 | $4,278 | -$702 | -$425 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,582 | -$2,629 | -$45,046 | $26,837 |
| Stock Issued | $71,635 | $0 | $14,122 | $108,477 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $223 | $354 | $34 | $1,518 |
| Financing Cash Flow | $70,276 | -$2,275 | -$30,890 | $136,832 |
| Forex Effect | $673 | $599 | $7,351 | $1,291 |
| Net Chg. in Cash | $30,483 | $24,150 | -$92,749 | $111,686 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $118,925 | $94,775 | $187,524 | $75,838 |
| End Cash | $149,408 | $118,925 | $94,775 | $187,524 |
| Free Cash Flow | -$37,811 | $20,177 | -$69,216 | -$26,496 |